Swildens Wilma, Termorshuizen Fabian, de Ridder Alex, Smeets Hugo, Engelhard Iris M
Altrecht Institute for Mental Health Care, Lange Nieuwstraat 119, 3512 PG, Utrecht, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Adm Policy Ment Health. 2016 Sep;43(5):650-662. doi: 10.1007/s10488-015-0679-0.
Patients with non-affective psychotic disorders (NAPD) face higher risk of somatic problems and early natural death compared to the general population. Therefore, treatment guidelines for schizophrenia and psychosis stress the importance of monitoring somatic risk factors. This study examined somatic Health Care utilization (HCu) of patients with NAPD compared to non-psychiatric controls and patients with depression, anxiety or bipolar disorders using a large Health Insurance database. Results show lower specialist somatic HCu of patients with NAPD compared to matched controls and also lower percentages for prescribed somatic medication and general practitioner consultations for patients aged ≥60 years and after longer illness duration.
与普通人群相比，非情感性精神障碍（NAPD）患者面临更高的躯体问题风险和过早自然死亡风险。因此，精神分裂症和精神病的治疗指南强调监测躯体风险因素的重要性。本研究使用一个大型健康保险数据库，比较了NAPD患者与非精神科对照以及患有抑郁症、焦虑症或双相情感障碍患者的躯体医疗保健利用情况（HCu）。结果显示，与匹配的对照组相比，NAPD患者的专科躯体HCu较低，而且60岁及以上患者以及病程较长的患者在开具躯体药物和全科医生会诊方面的比例也较低。
